Condition

Tricuspid Valve Regurgitation

ClinicalTrials.gov condition label

Clinical trials3

Recruiting0

Common interventions3

Lead sponsors shown3

Clinical trials

3 shown

A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.NCT06458907 · 2026-08-01

NOT_YET_RECRUITING

Structural Heart and Valve Network PROSPECTIVE RegistryNCT03928639 · 2023-01-10

WITHDRAWN

TRISCEND II Pivotal TrialNCT04482062 · 2021-04-09

ACTIVE_NOT_RECRUITING

Common interventions

Optimal Medical TherapyDRUG2Edwards EVOQUE SystemDEVICE1TricValve SystemDEVICE1

Leading sponsors

Edwards Lifesciences1National Heart, Lung, and Blood Institute (NHLBI)1P+F Products + Features USA Inc.1

Trial status mix

ACTIVE_NOT_RECRUITING1

NOT_YET_RECRUITING1

WITHDRAWN1

Phase mix

NA2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.